Medistim — Earnings Release 2018

Oct 25, 2018

Results for the third quarter 2018 for Medistim ASA

Results for the third quarter 2018 for Medistim ASA

Sales ended at MNOK 77.6 for the quarter (MNOK 77.7), a 2.5 % growth. Sales as of September increased by 4.0 % and ended at MOK 228.0 (MNOK 219.2). Revenue from own products showed a currency neutral decline of 0.4 % for the quarter and a currency neutral growth of 4.2 % YTD. Operating profit (EBIT) for the quarter ended at MNOK 14.5 (MNOK 19.4). Operating profit as of September ended at MNOK 46.2 (MNOK 49.1). There was a solid growth in system sales that creates the basis for future probe revenue. Number units year to date increases with 25.0 %. The final results from the REQUEST study was presented during EACTS in Milano. The study confirms the value of the combined use of flow and imaging.